Publications by authors named "Ann T Farrell"

Claim this Profile
R
Response Rate, Event-Free Survival, and Overall Survival in Newly Diagnosed Acute Myeloid Leukemia: US Food and Drug Administration Trial-Level and Patient-Level Analyses.
Kelly J Norsworthy, Xin Gao, Chia-Wen Ko, E Dianne Pulte, Jiaxi Zhou, Ann T Farrell

J Clin Oncol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic Review of PD-1/PD-L1 Inhibitors in Oncology: From Personalized Medicine to Public Health.
Elaine Chang, Lorraine Pelosof, Steven Lemery, Yutao Gong, Kirsten B Goldberg, Ann T Farrell

Oncologist· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Gilteritinib for Relapsed or Refractory Acute Myeloid Leukemia with a Mutation.
E Dianne Pulte, Kelly J Norsworthy, Yaping Wang, Qing Xu, Hisham Qosa, Ann T Farrell

Clin Cancer Res· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Second cancers in adults with acute promyelocytic leukemia treated with or without arsenic trioxide: a SEER-medicare analysis.
Kelly J Norsworthy, Armen Avagyan, Steven T Bird, Yuchen Li, Sandia Akhtar, Ann T Farrell

Leukemia· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Older adults in hematologic malignancy trials: Representation, barriers to participation and strategies for addressing underrepresentation.
Bindu Kanapuru, Harpreet Singh, Virginia Kwitkowski, Gideon Blumenthal, Ann T Farrell

Blood Rev· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differentiation Syndrome with Ivosidenib and Enasidenib Treatment in Patients with Relapsed or Refractory IDH-Mutated AML: A U.S. Food and Drug Administration Systematic Analysis.
Kelly J Norsworthy, Flora Mulkey, Emma C Scott, Ashley F Ward, Donna Przepiorka, Ann T Farrell

Clin Cancer Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA review summary of patient-reported outcome results for ibrutinib in the treatment of chronic graft versus host disease.
Bellinda L King-Kallimanis, Tanya Wroblewski, Virginia Kwitkowski, R Angelo De Claro, Thomas Gwise, Ann T Farrell

Qual Life Res· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Tagraxofusp-erzs For Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm.
Emily Y Jen, Xin Gao, Liang Li, Luning Zhuang, Natalie E Simpson, Ann T Farrell

Clin Cancer Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Mogamulizumab-kpkc for Mycosis Fungoides and Sézary Syndrome.
Yvette L Kasamon, Haiyan Chen, R Angelo de Claro, Lei Nie, Jingjing Ye, Ann T Farrell

Clin Cancer Res· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
End points for sickle cell disease clinical trials: renal and cardiopulmonary, cure, and low-resource settings.
Ann T Farrell, Julie Panepinto, Ankit A Desai, Adetola A Kassim, Jeffrey Lebensburger

Blood Adv· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
End points for sickle cell disease clinical trials: patient-reported outcomes, pain, and the brain.
Ann T Farrell, Julie Panepinto, C Patrick Carroll, Deepika S Darbari, Ankit A Desai

Blood Adv· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Glasdegib for Newly Diagnosed Acute Myeloid Leukemia.
Kelly J Norsworthy, Kunthel By, Sriram Subramaniam, Luning Zhuang, Pedro L Del Valle, Ann T Farrell

Clin Cancer Res· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Ivosidenib for Relapsed or Refractory Acute Myeloid Leukemia with an Isocitrate Dehydrogenase-1 Mutation.
Kelly J Norsworthy, Lola Luo, Vicky Hsu, Ramadevi Gudi, Sarah E Dorff, Ann T Farrell

Clin Cancer Res· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia.
Aviva C Krauss, Xin Gao, Liang Li, Michael L Manning, Paresma Patel, Ann T Farrell

Clin Cancer Res· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Brentuximab Vedotin in First-Line Treatment of Peripheral T-Cell Lymphoma.
Nicholas C Richardson, Yvette L Kasamon, Haiyan Chen, R Angelo de Claro, Jingjing Ye, Ann T Farrell

Oncologist· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval: Blinatumomab for Patients with B-cell Precursor Acute Lymphoblastic Leukemia in Morphologic Remission with Minimal Residual Disease.
Emily Y Jen, Qing Xu, Aaron Schetter, Donna Przepiorka, Yuan Li Shen, Ann T Farrell

Clin Cancer Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Midostaurin for the Treatment of Advanced Systemic Mastocytosis.
Yvette L Kasamon, Chia-Wen Ko, Sriram Subramaniam, Lian Ma, Yuching Yang, Ann T Farrell

Oncologist· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Supplemental Approval: Blinatumomab for Treatment of Relapsed and Refractory Precursor B-Cell Acute Lymphoblastic Leukemia.
E Dianne Pulte, Jonathon Vallejo, Donna Przepiorka, Lei Nie, Ann T Farrell

Oncologist· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Relationship Between AUEC of Absolute Neutrophil Count and Duration of Severe Neutropenia for G-CSF in Breast Cancer Patients.
Liang Li, Lian Ma, Sarah J Schrieber, Nam Atiqur Rahman, Albert Deisseroth, Ann T Farrell

Clin Pharmacol Ther· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia.
Kelly J Norsworthy, Chia-Wen Ko, Jee Eun Lee, Jiang Liu, Christy S John, Ann T Farrell

Oncologist· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome.
Robert Q Le, Liang Li, Weishi Yuan, Stacy S Shord, Lei Nie, Ann T Farrell

Oncologist· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval: Gemtuzumab Ozogamicin for the Treatment of Adults with Newly Diagnosed CD33-Positive Acute Myeloid Leukemia.
Emily Y Jen, Chia-Wen Ko, Jee Eun Lee, Pedro L Del Valle, Antonina Aydanian, Ann T Farrell

Clin Cancer Res· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Lenalidomide as Maintenance Therapy After Autologous Stem Cell Transplant in Newly Diagnosed Multiple Myeloma.
Elizabeth Dianne Pulte, Andrew Dmytrijuk, Lei Nie, Kirsten B Goldberg, Amy E McKee, Ann T Farrell

Oncologist· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A 25-Year Experience of US Food and Drug Administration Accelerated Approval of Malignant Hematology and Oncology Drugs and Biologics: A Review.
Julia A Beaver, Lynn J Howie, Lorraine Pelosof, Tamy Kim, Jinzhong Liu, Ann T Farrell

JAMA Oncol· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FDA Approval Summary: Daratumumab for Treatment of Multiple Myeloma After One Prior Therapy.
Vishal Bhatnagar, Nicole J Gormley, Lola Luo, Yuan Li Shen, Rajeshwari Sridhara, Ann T Farrell

Oncologist· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis